NCT03221907View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

April 11, 2016

Primary Completion Date

January 8, 2019

Study Completion Date

January 8, 2019

Conditions
Pain of Mononeuropathy
Interventions
DRUG

GLA5PR GLARS-NF1

Pregabalin tablet

DRUG

GLA5PR GLARS-NF1 placebo

tablet manufactured to mimic GLA5PR GLARS-NF1

DRUG

Pregabalin

Pregabalin capsule

DRUG

Pregabalin placebo

tablet manufactured to mimic pregabalin capsule

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT03221907 - Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter